Yahoo Web Search

Search results

1. • Treatment of Blood Cancers

     Digital Journal· 2 days ago

     (NYSE ...ARCs) and other targeted radiotherapies. Approximately every 3 minutes, one person in the US is diagnosed with leukemia, lymphoma or myeloma. This data from the & ...

2. • Hemogenyx Pharmaceuticals PLC Announces Operations Update

     Digital Journal· 3 days ago

     Operations Update LONDON, UNITED KINGDOM / ACCESSWIRE / June 17, 2024 / Hemogenyx Pharmaceuticals plc (LSE: HEMO), the clinical stage biopharmaceutical group developing treatments< ...

3. • Ayala Pharmaceuticals (NASDAQ:ADXS) Coverage Initiated by Analysts at StockNews.com

     ETF DAILY NEWS· 13 hours ago

     StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report report published on Wednesday morning. The firm issued a sell rating on the ...

4. • Live from EHA 2024 | Posters Featuring Results from Three Studies of Olverembatinib, Including...

     FOX 23 News Albany· 3 days ago

     In the results, olverembatinib showed excellent durable clinical benefits and favorable long-term tolerability in patients who had been treated with multiple TKIs (including those who were resistant ...

5. • Shattuck (STTK) Announces Positive Interim Data on Cancer Drug

     Zacks· 6 days ago

     SL-172154 is an investigational agonist redirected checkpoint fusion protein, designed to simultaneously inhibit the CD47/SIRPα checkpoint interaction and activate the CD40 costimulatory receptor ...

6. • Incyte (NASDAQ:INCY) Earns Neutral Rating from Cantor Fitzgerald

     ETF DAILY NEWS· 14 hours ago

     Incyte (NASDAQ:INCY – Get Free Report)‘s stock had its “neutral” rating restated by research analysts at Cantor Fitzgerald in a research note issued on Tuesday, Benzinga reports. A number of ...

7. • 

     Penny Stock Picks: 3 Companies Poised to Graduate to the Big Leagues

     InvestorPlace· 3 days ago

     You don’t want to overlook these three penny stocks filled to the brim with the potential to make...

8. • Incyte (NASDAQ:INCY) Sees Strong Trading Volume

     ETF DAILY NEWS· 3 days ago

     Incyte Co. (NASDAQ:INCY – Get Free Report) shares saw an uptick in trading volume on Monday . Jefferies Financial Group began coverage on shares of Incyte in a report on Friday, February 23rd ...

9. • Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's...

     Benzinga· 3 days ago

     Takeda Pharmaceutical Co Ltd TAK announced topline data from its SKYLINE and SKYWAY Phase 3 studies of Soticlestat (TAK-935) for the treatment of Dravet syndrome (DS) and ...

10. • Aptose Announces Results from Annual and Special Meeting of Shareholders

      Digital Journal· 2 days ago

      For more information, please visit www.aptose.com. Forward...